NILOGEN ONCOSYSTEMS
Nilogen Oncosystems is a contract research organization that offers cancer drug development services for pharmaceutical and biotechnology companies. In our CLIA-certified lab, Nilogen performs correlative studies between ex vivo drug responses and multiple aspects of the tumor microenvironment to develop companion diagnostics that can be applied to clinical trials and patient care. Our expert PhD scientists can assist drug developers throughout every phase of the project, from the design and execution of the study to the preparation of the final report, including interpretation of the data. Our proprietary drug testing platforms utilize fresh patient tumor tissue with intact tumor immune microenvironment to accurately assess the therapeutic potential of drug treatments.
NILOGEN ONCOSYSTEMS
Industry:
Biotechnology Health Care
Founded:
2013-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.nilogen.com
Total Employee:
11+
Status:
Active
Contact:
1(813)440-3588
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Medpace
Medpace, Inc., a clinical research organization, provides clinical development services for pharmaceutical and biotechnology
Current Employees Featured
Founder
Newest Events participated
Participated in ICI Boston 2017
on 2017-03-14 as sponsor
Official Site Inspections
http://www.nilogen.com
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nilogen Oncosystems"
3D Cancer Models | Nilogen Oncosystems
Jul 28, 2022 · Nilogen’s patented tumoroid technology is a 3D cancer model that captures the full heterogeneity of an individual tumor—including intact TME—in each well, enabling a more …See details»
About Us - Nilogen Oncosystems
Jul 28, 2022 · At Nilogen, we constantly innovate, evolve, and challenge ourselves to develop novel solutions for oncology and immuno-oncology drug development by interrogating tumor microenvironment in our patient-derived …See details»
Immuno Oncology Services - Nilogen Oncosystems
Build a detailed understanding of the effects of your therapeutic on the TME with our 3D-EXplore platform to discover drug mechanisms of action and identify biomarkers for clinical utility. The advantages of working with Nilogen go …See details»
Nilogen Oncosystems - Crunchbase Company Profile & Funding
Nilogen Oncosystems is a contract research organization that offers cancer drug development services for pharmaceutical and biotechnology companies. In our CLIA-certified lab, Nilogen …See details»
Nilogen Oncosystems - MassBio
Apr 7, 2023 · Nilogen Oncosystems is a CLIA-certified contract research organization offering immuno-oncology drug development services for pharmaceutical and biotechnology companies.See details»
Nilogen Oncosystems - LinkedIn
Nilogen Oncosystems is dedicated to streamlining and improving drug development in cancer and immuno-oncology. At Nilogen, we appreciate the complexity of cancer and use fresh patient tumor...See details»
Nilogen Oncosystems - VentureRadar
Nilogen Oncosystems is a CLIA-certified contract research organization offering immuno-oncology drug development services for pharmaceutical and biotechnology companies.See details»
Nilogen Oncosystems - Scientist.com
Nilogen Oncosystems partners with pharmaceutical and biotech companies in oncology drug development. Our ex vivo platform utilizes 3D tumoroids prepared from fresh patient tissue …See details»
Nilogen and Scailyte Are Joining Forces to Find the …
Jul 12, 2022 · This long-term strategic partnership aims at integrating Nilogen Oncosytems' proprietary 3D-EXplore Platform of fresh patient tumor tissue with Scailyte's AI Platform ScaiVision™ to develop a...See details»
Our Team - Nilogen Oncosystems
Our commitment to providing answers for our clients about advancing their immuno-oncology drug development is proven and yields unparalleled results. Our team is led by experienced and passionate doctors that are committed to …See details»
Nilogen and Scailyte Joining Forces to Find the “Right” …
Jul 12, 2022 · Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, a single cell AI biomarker discovery company, announced today a strategic partnership to increase the success rate of novel …See details»
Nilogen Oncosystems | Tampa FL - Facebook
Nilogen Oncosystems, Tampa, Florida. 186 likes. Nilogen Oncosystems is a contract research organization that offers cancer drug development services for pharmaceutical and biotechnology companies.See details»
2 Nilogen oncosystems’s 3D-PREDICT tumoroid model is an
Nilogen Oncosystem’s 3D-PREDICT is a novel ex vivo therapeutic investigative platform that provides a functional model of a patient’s tumor to directly investigate susceptibility to different …See details»
Nilogen Oncosystems, Scailyte Partner to Improve Precision …
Jul 14, 2022 · NEW YORK – Cancer drugmaker Nilogen Oncosystems this week said it has partnered with Scailyte, a firm discovering biomarkers using single-cell machine learning, to …See details»
1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid …
1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact …See details»
Careers - Nilogen Oncosystems
Join our growing medical oncology team - help test & develop immuno-oncology drugs that yield unparalleled results for our clients. View current openings.See details»
Nilogen Oncosystems - Biotech Careers
Nilogen’s patented tumoroid technology is a 3D cancer model that captures the full heterogeneity of an individual tumor—including intact TME—in each well, enabling a more accurate …See details»
500 Assessing the efficacy of immunotherapies using Nilogen …
By replicating clinical heterogeneity in a controlled setting, Nilogen’s platform facilitates the screening of precise immunotherapeutic agents, potentially reducing the bias, time and cost …See details»
Publications | Nilogen Oncosystems
Read the latest publications on our technology and applications. Need Help? View our high-impact, peer-reviewed medical oncology publications of significant clinical immuno-oncology …See details»
Nilogen Oncosystems Revenue and Competitors - Growjo
Nilogen Oncosystems is dedicated to streamlining and improving drug development in cancer and immuno-oncology. At Nilogen, we appreciate the complexity of cancer and use fresh patient …See details»